Revio GLP-1 Tracker: Shot Log is a health-tracking application for iOS that enables users to log GLP-1 medication doses, track injection sites, and monitor daily nutritional intake.
The App DNA
What makes this app unique?
The app removes the cognitive friction of tracking complex, multi-medication weight loss regimens by replacing manual notes with a visual, medication-specific logging workflow.
For Individuals prescribed GLP-1 medications for weight management who require structured tracking for doses, side effects, and nutritional goals.
What does it look like?
Key features
Logs doses for over 30 medications with injection site rotation tracking.
Displays daily goal progress via custom mascots and complications.
Logs protein, water, and fiber intake with barcode scanning.
How much does it cost?
Revio GLP-1 Tracker: Shot Log is currently free to use with no visible subscription or IAP gates.
Velocity
Maintenance developmentplatform expansionUX improvementsShow more...
The app currently operates at a maintenance cadence, with only one release shipped in the last 20 days. Development is focused on platform expansion and UX improvements, specifically enhancing the Apple Watch experience. Given the single release in the observed window, the development trend is stable but infrequent. Future updates are expected to follow this pattern of occasional feature additions rather than rapid iteration.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Revio GLP-1 Tracker: Shot Log
How's the Health & Fitness market?
Revio GLP-1 Tracker: Shot Log occupies a specialized health-tracking niche, currently holding a 4.57 rating on iOS. The absence of monetization gates suggests an early-stage focus on user acquisition over revenue generation.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Revio GLP-1 Tracker: Shot Log
Where is it heading?
Users report: The health-tracking market is consolidating around platforms that offer integrated, multi-source data insights. Revio GLP-1 Tracker: Shot Log remains exposed to larger incumbents, and its current trajectory requires a pivot toward a sustainable revenue model to ensure continued development.
- The latest release expanded Apple Watch functionality, signaling a focus on wearable-first engagement rather than broad feature expansion.
- The maintenance-level release cadence suggests limited engineering resources, which may delay responses to competitor feature updates.
The SWOT
- Visual injection site rotation map reduces patient error
- Apple Watch mascots drive daily engagement loops
- Integrate CGM data to provide deeper health insights
Next best moves
Implement a premium subscription tier because the current free-only model lacks long-term revenue sustainability → increase LTV
+ 1 more prioritized moveThe counter-intuitive read
The lack of monetization is a strategic advantage…
Read the full takeSince the last report: The product strategy shifted from a focus on feature parity to an urgent prioritization of monetization and retention analytics. The outlook is now more critical of the app's limited engineering capacity and its vulnerability to larger incumbents.
Bottom line
Revio GLP-1 Tracker: Shot Log provides high-utility tracking for a specific patient segment, but the lack of a monetization strategy risks long-term viability. Introducing a premium tier would unlock revenue from power users who rely on the specialized logging workflow.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated